ATE249475T1 - Oligonukleotid-analoge - Google Patents

Oligonukleotid-analoge

Info

Publication number
ATE249475T1
ATE249475T1 AT97905245T AT97905245T ATE249475T1 AT E249475 T1 ATE249475 T1 AT E249475T1 AT 97905245 T AT97905245 T AT 97905245T AT 97905245 T AT97905245 T AT 97905245T AT E249475 T1 ATE249475 T1 AT E249475T1
Authority
AT
Austria
Prior art keywords
attached
group
unsubstituted
cycloalkyl
alkenyl
Prior art date
Application number
AT97905245T
Other languages
English (en)
Inventor
Anthony David Baxter
Stephen Paul Collingwood
Mark Edward Douglas
Roger John Taylor
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE249475T1 publication Critical patent/ATE249475T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97905245T 1996-03-05 1997-02-24 Oligonukleotid-analoge ATE249475T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9604669.3A GB9604669D0 (en) 1996-03-05 1996-03-05 Chemical compounds
PCT/GB1997/000499 WO1997032887A1 (en) 1996-03-05 1997-02-24 Oligonucleotide analogues

Publications (1)

Publication Number Publication Date
ATE249475T1 true ATE249475T1 (de) 2003-09-15

Family

ID=10789879

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97905245T ATE249475T1 (de) 1996-03-05 1997-02-24 Oligonukleotid-analoge

Country Status (12)

Country Link
US (1) US6562960B1 (de)
EP (1) EP0885237B1 (de)
JP (1) JP2000506849A (de)
CN (1) CN1212701A (de)
AT (1) ATE249475T1 (de)
AU (1) AU1886797A (de)
BR (1) BR9707918A (de)
CA (1) CA2247480A1 (de)
DE (1) DE69724768T2 (de)
GB (1) GB9604669D0 (de)
WO (1) WO1997032887A1 (de)
ZA (1) ZA971849B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6639061B1 (en) * 1999-07-07 2003-10-28 Isis Pharmaceuticals, Inc. C3′-methylene hydrogen phosphonate oligomers and related compounds
US6414135B1 (en) 1999-07-07 2002-07-02 Isis Pharmaceuticals, Inc. C3′-methylene hydrogen phosphonate monomers and related compounds
WO2003052134A2 (en) * 2001-12-18 2003-06-26 Human Genetic Signatures Pty Ltd Oligonucleotides comprising intercalator pseudonucleotide(s) for detection of nucleic acids and mutants hereof
FR2858976B1 (fr) * 2003-08-22 2006-02-10 Isochem Sa Procede d'obtention de n-carboxyanhydrides d'alpha-aminoacides a protection urethane
WO2009023855A2 (en) * 2007-08-15 2009-02-19 Isis Pharmaceuticals, Inc. Tetrahydropyran nucleic acid analogs
SG171914A1 (en) 2008-12-02 2011-07-28 Chiralgen Ltd Method for the synthesis of phosphorus atom modified nucleic acids
EP2451461A4 (de) 2009-07-06 2013-05-29 Ontorii Inc Neuartige nukleinsäure-prodrugs und verwendungsverfahren dafür
DK2620428T3 (da) 2010-09-24 2019-07-01 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
US9605019B2 (en) 2011-07-19 2017-03-28 Wave Life Sciences Ltd. Methods for the synthesis of functionalized nucleic acids
JP6246121B2 (ja) 2012-07-13 2017-12-13 株式会社新日本科学 キラル核酸アジュバント
DK2872485T3 (da) 2012-07-13 2021-03-08 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
CN112007045B (zh) 2012-07-13 2026-01-06 波涛生命科学有限公司 手性控制
WO2015108048A1 (ja) 2014-01-15 2015-07-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
EP3095461A4 (de) 2014-01-15 2017-08-23 Shin Nippon Biomedical Laboratories, Ltd. Chirales nukleinsäure-adjuvans mit immunitätsinduktionswirkung und immunitätsinduktionsaktivator
US10322173B2 (en) 2014-01-15 2019-06-18 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
KR102423317B1 (ko) 2014-01-16 2022-07-22 웨이브 라이프 사이언시스 리미티드 키랄 디자인

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469863A (en) * 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US4507433A (en) * 1983-10-07 1985-03-26 The Johns Hopkins University Preparation of oligodeoxyribonucleoside alkyl or arylphosphonates
US4806463A (en) 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
EP0266099A3 (de) 1986-10-28 1990-09-19 The Johns Hopkins University Alkyl- oder Arylphosphonat-Oligonukleosid, das sich mit Nukleinesäuren vernetzen kann oder das Nukleinsäure spalten kann
GB8721442D0 (en) 1987-09-11 1987-10-21 Ciba Geigy Ag Process
EP0402402B1 (de) 1988-02-26 1995-12-27 Worcester Foundation For Biomedical Research, Inc. Hemmung von htlv-iii durch exogene oligonukleotide
DK0942000T3 (da) 1989-10-24 2004-11-01 Isis Pharmaceuticals Inc 2'-modificerede oligonukleotider
US5610289A (en) * 1990-07-27 1997-03-11 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogues
US5378825A (en) 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
US6033909A (en) * 1992-01-22 2000-03-07 Hoechst Aktiengesellschaft Oligonucleotide analogs, their preparation and use
US5681747A (en) 1992-03-16 1997-10-28 Isis Pharmaceuticals, Inc. Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof
US5625050A (en) * 1994-03-31 1997-04-29 Amgen Inc. Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
US5563255A (en) * 1994-05-31 1996-10-08 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of raf gene expression
GB9417746D0 (en) 1994-09-03 1994-10-19 Ciba Geigy Ag Chemical compounds

Also Published As

Publication number Publication date
GB9604669D0 (en) 1996-05-01
CN1212701A (zh) 1999-03-31
BR9707918A (pt) 1999-07-27
DE69724768T2 (de) 2004-08-05
US6562960B1 (en) 2003-05-13
ZA971849B (en) 1997-09-05
EP0885237A1 (de) 1998-12-23
EP0885237B1 (de) 2003-09-10
AU1886797A (en) 1997-09-22
DE69724768D1 (de) 2003-10-16
CA2247480A1 (en) 1997-09-12
WO1997032887A1 (en) 1997-09-12
JP2000506849A (ja) 2000-06-06

Similar Documents

Publication Publication Date Title
BR9707918A (pt) Análogos de oligonucleotídeos
CO4560475A1 (es) Un producto de carbon modificado
ES2036551T3 (es) Compuestos heterociclicos.
DK0802188T3 (da) Heteroforbundne phenylglycinolamider som antiatherosklerotiske lægemidler
ATE231918T1 (de) Verfahren zur fermentativen herstellung von l- cystein oder l-cystein-derivaten
ES2066991T3 (es) Agentes hipoglucemiantes de oxazolidinadiona.
EA199800768A1 (ru) Новые производные эритромицина, способ их получения и их применение в качестве медикаментов
DE69611773D1 (de) 13-Substituierte Milbemycin 5-Oxim Derivate, ihre Herstellung und Verwendung gegen Insekten und andere Schädlinge
ES2164164T3 (es) Derivados de aminotetrazol utiles como inhibidores de oxido nitrico sintasa.
TW258735B (de)
ATE132139T1 (de) Diaminoethylen-verbindungen
AU2148595A (en) 4,6-di-t-butyl-2,3-dihydrobenzothiophene derivative
ATE189203T1 (de) Trizyklische derivate, ihre herstellung, ihre verwendung zur herstellung von optisch aktivem oder racemischem colchizin, thiocolchizin, dessen analoge oder derivate, und intermediate
ES2059595T3 (es) Beta-carbonil-carboxiamidas de 1,3-tiazolidinas.
ATE328055T1 (de) Substituierte lineare thioureaverbindungen als schmiermittelzusatzstoff
PT906295E (pt) Dibenzo-oxazepina e derivados de dioxepina e a respectiva utilizacao como agentes anti-tumores
DE69830653D1 (en) Chelatisierungsmitteln
ATE210675T1 (de) Zwischenprodukten für oligonukleotid-synthese
PT695296E (pt) Derivados de acidos 3-ariloxi-carboxilicos e processo para a sua preparacao
AU4195893A (en) Alkylenediamine derivatives
ATE155785T1 (de) Mitomycinderivate
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
ES529415A0 (es) Procedimiento para la preparacion de derivados de piridin-pirimidinona
IL94898A (en) Preparation of s-2,2,r1. r2-1,3-dioxolane-4- methanols
DE3664467D1 (de) Pineapple ketone l'alkoxyalkyl derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties